4

Click here to load reader

Honey for Treatment of Cough in Children - Feasibility Study

Embed Size (px)

DESCRIPTION

Respiratory tract infections are an important health problem because of high incidence and economic costs. The World Health Organization identifies honey as a potential demulcent treatment for cough. This study concludes that a RCT (randomized controlled trial) to determine the effects of honey versus placebo is feasible.

Citation preview

Page 1: Honey for Treatment of Cough in Children - Feasibility Study

[Pediatric Reports 2013; 5:e8] [page 31]

Feasibility study: honey fortreatment of cough in childrenNaveed Ahmed,1 Alastair Sutcliffe,2Claire Tipper2

1Univeristy College London MedicalSchool, London; 2General and AdolescentPaediatric Unit, Institute of Child Health,University College London, UK

Abstract

Respiratory tract infections are an impor-tant health problem because of high incidenceand economic costs. The World HealthOrganization identifies honey as a potentialdemulcent treatment for cough. The aim ofthis study is to determine: i) patient publicperceptions towards a proposed randomizedcontrolled trial (RCT) comparing the effects ofhoney to placebo for treatment of cough inchildren; ii) potential participation rates forproposed trial; iii) whether age and gender ofparent or child impacts on proposed coughassessment tools. Forty adult participants withchildren age 1-6 years presenting with anupper respiratory tract infection were enrolled.They underwent a structured interview regard-ing the proposed trial and assessed theirchild’s cough using two validated question-naires. Eighty-eight percent of those recruitedwere willing to participate in the proposedtrial. The two independently validated coughscores correlated well. A relationship betweenage and gender of child or parent with coughassessment score was not found. We concludethat a RCT to determine the effects of honeyversus placebo is feasible. The public find theoutcome measures and trial design acceptable.

Introduction

OverviewCoughing is a protective reflex action trig-

gered by irritation or obstruction of the air-ways. Excess secretions and foreign bodies arecleared from the lungs by a combination ofcoughing and the mucociliary escalator.1Physiologically a cough is a forced expirationagainst a closed glottis.2All children experience coughs and commu-

nity based surveys show that parental reportedcough as an isolated symptom has a highprevalence.3 Cough has an impact on a child’sability to sleep, play and eat. It may disturbother family members’ sleep and be disruptiveat school. Acute coughs, usually caused by aviral upper respiratory tract infection (URTI),

are self-limiting whereas chronic coughs aredefined as those lasting longer than 8 weeks.4Symptomatic URTI occurs in school age chil-dren on average 7-10 times a year.2Cough constitutes 12 million GP visits per

year, the largest single cause of primary careconsultation, however, present UK generalpractice guidelines advise no treatment shouldbe given.2 The mean cost per episode to theNHS is £ 27.43, to the parent £ 14.77 and annu-ally to the NHS at least £ 31.5.5

Current treatmentOver the counter cough medicines include

combinations of antihistamines, decongestants,antitussives and expectorants. Systematicreviews show no evidence these products are ofbenefit compared to placebo.6,7 Despite this theUK market for these products in 2009 was worth£ 437.2 million.8,9There have been multiple reports of adverse

effects associated with cough medicines. Inchildren under 6 years of age decongestantshave been linked to cardiac arrhythmias, anti-histamines to hallucinations, and antitussivesto depressed levels of consciousness andencephalopathy.7 Hospital episode statistics forEngland 2006/7 showed 230 children under 14were admitted to hospital as a consequence ofexposure to antitussives, expectorants or com-mon cold remedies (11 poisoning by antitus-sives, 39 poisoning by expectorants, 182 poison-ing by common cold remedies).10 The USA theFood and Drug administration identified 123deaths related to the use of such products.7The Medicines and Healthcare products

Regulatory Agency (MHRA) now advises chil-dren less than 6 years old should not be treat-ed with over the counter cough and cold med-ication.11 Carers have been advised that chil-dren suffering from cough should be treatedwith a simple cough syrup (such as glycerol,honey or lemon).1

HoneyThe World Health Organization regards

honey as a potentially valuable demulcent forthe treatment of cough.12 Honey is a sweet vis-cous liquid with a complex chemical composi-tion of carbohydrates, free amino acids, vita-mins, trace elements and flavonoids. It alsocontains compounds that function as antioxi-dants. It is said to possess anti-bacterial, anti-viral and anti-inflammatory properties.13,14Studies of the antimicrobial effect of honey

have demonstrated its broad-spectrum antimi-crobial actions against various gram-positiveand gram-negative bacteria. It is also activeagainst common bacteria found in the upperrespiratory tract such as Staphylococcusaureus and Streptococcus faecalis, amongstothers.14 Honey has been used in traditionalmedicine for the treatment of cough and isused in modern medicine to treat wounds and

aid healing processes.15 The use of honey isprohibited under the age of one due to poorimmunity against Clostridium Botulinum, apotential contaminant.16,17 A review by Eccles, argues that the sweet-

ness of liquid preparations used to treat coughaccounts for much of the observed effect.18 Thehypothesis suggests sweet substances natural-ly cause reflex salivation and production of air-way mucus leading to a demulcent effect onthe pharynx and larynx, thereby reducingcough. It is suggested that there is interactionbetween opioid-responsive sensory fibers andthe gustatory nerves to help produce an anti-tussive effect via the central nervous system.18

Assessment of coughTwo validated measures of cough severity

have recently been developed. The CanadianAcute Respiratory Illness and Flu Scale (CAR-IFS) is composed of 18 items covering threedomains; symptoms (e.g. cough), function (e.g.ability of child to play) and parental impact(e.g. clinginess).19 A validated Pediatric coughquestionnaire with a 7 point Likert Scale hasalso been developed by Paul et al.20

Purpose of studyThis paper describes a feasibility study for a

Pediatric Reports 2013; volume 5:e8

Correspondence: Claire Tipper, General andAdolescent Paediatric Unit, Institute of ChildHealth, University College London, 30 GuilfordStreet, London, WC1N 1EH, UK.Tel. +44.207.905.2190 - Fax: +44.207.905.2834.E-mail: [email protected]

Key words: upper respiratory infections, commoncold, pediatrics, primary care, community medi-cine, common illnesses.

Acknowledgements: the authors would like tothank Green Light Pharmacy in Euston for theirparticipation in this study. Ethical approval wasobtained from UCL ethics committee Alpha.

Contributions: NA, data collecting, analyzing andmanuscript writing; AS, manuscript reviewing;CT, manuscript writing.

Conflict of interests: the authors declare nopotential conflict of interests.

Received for publication: 5 March 2013.Accepted for publication: 2 April 2013.

This work is licensed under a Creative CommonsAttribution NonCommercial 3.0 License (CC BY-NC 3.0).

©Copyright N. Ahmed et al., 2013Licensee PAGEPress, ItalyPediatric Reports 2013; 5:e8doi:10.4081/pr.2013.e8

Page 2: Honey for Treatment of Cough in Children - Feasibility Study

[page 32] [Pediatric Reports 2013; 5:e8]

randomized controlled trial regarding the roleof honey for the symptomatic relief of cough inchildren with self-limiting upper respiratorytract infections. Further to this we plan to con-duct a pilot study to determine whether theproposed methods and instruments are appro-priate and identify any potential practical diffi-culties with a larger study.8

ObjectivesThe principal objective is to determine pub-

lic perception towards the proposed trialdesign and intervention as well as acceptabili-ty to families. The secondary objectives are to estimate

potential participation rates and to determinewhether there is any correlation between thecough assessment questionnaire results andage or gender of parent or child.

Materials and Methods

An interview and questionnaire based studywas used to determine the feasibility of a ran-domized controlled trial. The setting was abranch of the Green Light Pharmacy in Euston,a prominent community pharmacy. The inclu-sion criteria were; parents of children betweenthe ages of one and six years presenting withcough as part of an URTI to the communitypharmacy. Exclusion criteria were underlyingrespiratory illnesses, at the pharmacist’s dis-cretion.

ConsentThe pharmacist introduced the parent to the

student conducting the survey. The studentdiscussed the information sheet and obtainedwritten informed consent.

InterviewAfter consent had been obtained the student

conducted a 15 question interview with theparticipant. This included questions regardingawareness of alternative cough treatments(including honey), use of over the countermedicines and willingness to participate in aproposed future trial.

Cough assessmentThe participant was asked to fill in two vali-

dated questionnaires to assess their child’scough. The 5 domain validated questionnairewas chosen as it was used in the only pub-lished randomized controlled trial investigat-ing the effect of honey on cough in young chil-dren to date.20 The 18 item CARIFS is a validmeasure of functional severity and burden ofillness to the parent.14 Using both question-naires maximized our ability to assess coughseverity and its impact on both the child andparent. The raw data was entered into

Microsoft Excel verbatim and coding wasapplied to allow the data to be analyzed inSPSS. The data was normalized to comparequestionnaires.

Results

Forty adult participants were enrolled in thestudy, mean age 32 (range: 22-55). The meanage of the children was 3 years (range 1-6years). The results showed 88% of participants

would be willing to take part in the proposedtrial (Figure 1); 39 of the 40 participants werecontent to use honey to treat their child’s cough.On questioning only 65% were willing to fill in adiary continuously for a five day period. The scores generated by the participants on

both the CARIF and the Paul et al. question-naire are shown in Figure 2. There was astrong positive correlation between the ques-tionnaires (Figure 3) and using SPSS, a signif-icant (P<0.01) Pearson product moment corre-lation coefficient was calculated (0.66). A Bland-Altman plot was constructed to ana-

Article

Figure 2. A comparison between the scores obtained on the Canadian Acute RespiratoryIllness and Flu Scale and Paul et al. questionnaire. The data has been normalized.

Figure 1. Participation rates for the proposed Randomized Controlled Trial.

Page 3: Honey for Treatment of Cough in Children - Feasibility Study

[Pediatric Reports 2013; 5:e8] [page 33]

lyze agreement between the two different vari-ables (Figure 4). This showed an acceptablecorrelation of 0.46. The results from the cough assessment ques-

tionnaire were comparable to the initial trialused to validate the CARIF questionnaire. Themean score for the CARIF validating trial was27.99 (95% CI: 38.25-17.73). Our sample of datahad a mean of 25.35 (95% CI: 38.27-12.43). Theoverlapping confidence intervals show that theparticipants in this trial were comparable tothose used in the validation trial.There was no correlation between the gen-

der or age of parent or child with the totalscore for either CARIF or Paul et al. (Table 1).If there was such a correlation this wouldquestion the validity.A t test was used to compare the parent’s

gender (P=0.91) and the child’s gender(P=0.344) with the final score in the coughassessment questionnaire. The confidenceintervals overlapped confirming no statisticallysignificant difference in cough assessment. To further support this a linear regression

model was also used to determine whetherthere was a relationship between the gender ofan individual assessing their child and the finalscore in each of the questionnaires. The confi-dence intervals for male and female overlappedfor both CARIF and Paul et al. therefore no sig-nificant difference was seen. There was there-fore no relationship between the parents’ gen-der and total scores on either questionnaire.

Discussion

Cough caused by URTI can be a troublingsymptom for both children and their parents,who are often keen for treatment. However, asystematic review conducted by Schroeder etal., in 2004 shows that there is little evidencefor the effectiveness of over the counter coughmedicines.6 The NHS encourages self-medica-tion for acute self-limiting illnesses and theWorld Health Organization has recommendedhoney for its topical demulcent effect in treat-ing cough.12This study demonstrates that the public

would be willing to participate in a trial inves-tigating the effects of honey in comparison toplacebo for the treatment of cough in children.The measures that we propose to use areacceptable to the public and the figures forpotential recruitment are high.This feasibility study involved 40 partici-

pants. One reason for the small sample size isthat the study was conducted from Januaryonwards. Ideally, the main trial would start inNovember to maximize potential recruitmentrates as the highest incidence of upper respiratory tract infections are between Octoberand February. We propose to follow this feasi-

Article

Figure 3. Scatter graph comparison of the Canadian Acute Respiratory Illness and FluScale with Paul et al.

Figure 4. Bland Altman plot for Canadian Acute Respiratory Illness and Flu Scale andPaul et al. questionnaire.

Page 4: Honey for Treatment of Cough in Children - Feasibility Study

[page 34] [Pediatric Reports 2013; 5:e8]

bility study with a pilot trial where 270 individ-uals will be randomized to honey or placebo.

InterviewOn questioning the potential participation

rate for the trial was 88% but only 65% werewilling to fill in a diary continuously for a fiveday period. Participants initially felt filling outthe questionnaires would be too time consum-ing, especially if parents had other children tolook after or were working. However, after com-pleting the questionnaire and realizing theshort amount of time required, parents werethen willing to reconsider. This observation wasnot reflected in the results and therefore thepercentage of people willing to keep a diary islikely to be higher. The questionnaire currentlyexcludes non English speakers. Fortunately thearea that we conducted the study was inhabitedby a large Bangladeshi and Pakistani populationwith whom the student was able to communi-cate. Some people were excluded due to lan-guage difficulties which may be overcome byusing translated questionnaires.

Cough assessmentThe results from the cough assessment

questionnaire were comparable to the initialtrial used to validate the CARIF questionnaire.

ResultsThere was no statistically significant rela-

tionship when comparing the age or gender ofthe parent to the total score when assessingtheir child’s cough. Similarly the gender of thechild had no effect on the assessment of thechild’s cough.

Future workThe next stage of the trial is to conduct a pilot

study. We propose a double blind randomizedcontrolled trial comparing honey with placeboduring the winter season. This will allow us torefine our methodology and calculate the ade-quate sample size required for a full study.

Conclusions

In conclusion, this feasibility study is a valu-able indicator for the potential success of aproposed future randomized controlled trial.The data collected corresponds well with previ-ous trials in the field and the outcome meas-ures proposed in the study are acceptable tothe public. The questionnaires were filled inwithout difficulty by English speakers andthere was a general positive attitude towardsthe trial. Age and gender of parent or child didnot appear to affect cough assessment whichwas reassuring.

References

1. Rutter P. Community pharmacy: symp-toms, diagnosis and treatment. 2nd ed.Churchill Livingstone; 2009.

2. Morice AH, McGarvey L, Pavord I.Recommendations for the management ofcough in adults. Thorax 2006;61 Suppl1:i1-24.

3. Ninan TK, Macdonald L, Russell G.Persistent nocturnal cough in childhood: apopulation based study. Arch Dis Child1995;73:403-7.

4. Morice AH. Epidemiology of cough. PulmPharmacol Ther 2002;15:253-9.

5. Hollinghurst S, Gorst C, Fahey T, Hay AD.Measuring the financial burden of acutecough in pre-school children: a cost of ill-ness study. BMC Fam Pract 2008;9:10

6. Schroeder K, Fahey T. Over-the-countermedications for acute cough in childrenand adults in ambulatory settings.Cochrane Database Syst Rev 2004:CD001831.

7. Sharfstein JM, North M, Serwint JR. Overthe counter but no longer under the radar--pediatric cough and cold medications. N

Engl J Med 2007;357:2321-4.8. Evans H, Tuleu C, Sutcliffe A. Is honey awell-evidenced alternative to over-the-counter cough medicines? J R Soc Med2010;103:164-5.

9. PAGB. The Proprietary association ofGreat Britain annual review and report2010. London: The Proprietary Associationof Great Britain; 2010.

10. MHRA. Overview: risk benefit of cough andcold medicines in children. Available from:http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con041374.pdf.

11. MHRA. Drug safety update 2009. Availablefrom: http://www.mhra.gov.uk/home/groups/pl-p/documents/publication/con043810.pdf.

12. WHO. Cough and cold remedies for thetreatment of acute respiratory infectionsin young children 2001. Geneva: WorldHealth Organization; 2001.

13. Sanz ML, Gonzalez M, de Lorenzo C, et al.Carbohydrate composition and physicochemical properties of artisanal honeysfrom Madrid (Spain): occurrence ofEchium sp honey. J Sci Food Agric 2004;84:1577-84.

14. Mullai V, Menon T. Bactericidal activity ofdifferent types of honey against clinicaland environmental isolates of pseudo-monas aeruginosa. J Altern ComplementMed 2007;13:439-41.

15. Simon A, Traynor K, Santos K, et al.Medical honey for wound care —still thelatest resort? Evid Based ComplementAlternat Med 2009;6:165-73.

16. Kuplulu O, Goncuoglu M, Ozdemir H, et al.Incidence of Clostridium botulinum sporesin honey in Turkey. Food Control2006;17:222-4.

17. Nevas M, Hielm S, Lindstrom M, et al. Highprevalence of Clostridium botulinum typesA and B in honey samples detected by poly-merase chain reaction. Int J Food Micro-biol 2002;72:45-52.

18. Eccles R. Mechanisms of the placebo effectof sweet cough syrups. Respir PhysiolNeurobiol 2006;152:340-8.

19. Jacobs B, Young NL, Dick PT, et al.Canadian acute respiratory illness and fluscale (CARIFS): Development of a validmeasure for childhood respiratory infec-tions. J Clin Epidemiol 2000;53:793-9.

20. Paul IM, Beiler J, McMonagle A, et al.Effect of honey, dextromethorphan, and notreatment on nocturnal cough and sleepquality for coughing children and theirparents. Arch Pediatr Adolesc Med 2007;161:1140-6.

Article

Table 1. Results of Pearson correlation coefficient and its significance. Cough scoreresults analyzed for differences depending on age or gender of child and parent.

CARIF Paul et al.Correlation Significance Correlation Significance

Participant gender 0.120 0.460 0.018 0.911Participant age 0.314 0.052 -0.002 0.989Child’s gender -0.300 0.852 -0.153 0.345Child’s age -0.330 0.841 -0.310 0.850